Therapeutic Solutions International CEO Issues Shareholder Letter Dec 31, 2018 09:00AM
Therapeutic Solutions International, Inc. (TSOI) Reports Complete Phase 1 Clinical Trial in Advanced Cancer Patients Using its StemVacs Cellular Immunotherapy Sep 4, 2018 09:02AM
Therapeutic Solutions International Completes Phase 1 Clinical Trial in Advanced Cancer Patients for Right to Try Access of its StemVacs Product for American Cancer Patients Sep 4, 2018 09:00AM